Featured
How high-definition spatial transcriptomics, single cell FFPE, and Xenium are tackling the cancer problem showcased at AACR 2024
In her opening plenary session at AACR 2024, Aviv Regev, PhD, Head of Genentech Research and Early Development, pointed out the huge problem—indeed, the potentially overwhelming problem—of cancer. There are > 100 different cancer types, 10,000 known driver mutations, complex circuits driving cancer biology within and between cells in the tumor microenvironment, and an almost unfathomable number of possible small molecules and antibody structures to consider for drug development.
Olivia Habern
All Products
All Areas of Interest